Novel treatments for respiratory disease

Oral Presentation
Chairs: C. Page (London, United Kingdom), M. Cazzola (Rome, Italy)
The inhaled PDE4 inhibitor GSK256066 significantly inhibits airway responses following allergen challenge in asthmatics
D. Singh, L. Cass, F. Pétavy, B. O‘Connor (Manchester, Stevenage, Greenford, London, United Kingdom)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
The in vitro biology of Compound X – a novel β2 adrenoceptor agonist with a long duration of action
M. Coghlan, C. Shepherd, S. Summerhill, S. Patel, M. Yeadon, C. Perros-Huguet, N. Clarke, M. Trevethick (Sandwich, Kent, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD
D. Singh, L. Smyth, Z. Borrill, L. Kent, L. Sweeney, C. Clayton, P. Linacre, M. DeSouza, R. Vessey, R. Tal-Singer (Manchester, United Kingdom; Philadelphia, PA, United States Of America)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Safety and tolerability of NVA237, a once daily long-acting muscarinic antagonist, in patients with COPD
C. Vogelmeier, C. Verkindre, D. Cheung, J. B. Galdiz, S. Z. Guclu, S. Spangenthal, T. Overend, M. Henley, G. Mizutani, R. Zeldin, G. Geba (Marburg, Germany; Beuvry, France; Schiedam, Netherlands; Baracaldo, Spain; Izmir, Turkey; New Jersey, United States
Congress or journal article abstract
Congress or journal article abstract
Once-daily administration of aclidinium bromide, a novel, long-acting anticholinergic: a phase II, dose-finding study
P. Chanez, S. Burge, R. Dahl, J. Creemers, R. Lamarca, E. Garcia Gil (Marseille, France; Birmingham, United Kingdom; Aarhus, Denmark; Eindhove, Netherlands; Barcelona, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
In vivo pulmonary deposition of aclidinium bromide from a multidose dry powder inhaler
S. Newman, D. Sutton, R. Segarra, R. Lamarca, G. de Miquel (Nottingham, United Kingdom; Barcelona, Spain)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction
K. Wright, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Pretreatment with inhaled HSP20 transducible phosphopeptide attenuates bronchoconstriction in naïve dogs
E. G. Barrett, K. Rudolph, P. J. Kuehl, C. M. Brohpy, M. R. Sheller (Albuquerque, NM, Tempe, AZ, Phoenix, AZ, United States Of America)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation